✦ LIBER ✦

Timing hormonal therapy in prostate cancer

✍ Scribed by Sessions, Annette E; Messing, Edward M

Book ID: 122704404
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 54 KB
Volume: 29
Category: Article
ISSN: 0094-0143
DOI: 10.1016/S0094-0143(02)00007-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

296 - Timing of hormonal therapy in pros

296 - Timing of hormonal therapy in prostate cancer

✍ D. Mellonl; M. Pavone-Macaluso 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 252 KB

Timing of Salvage Hormonal Therapy in Pr

Timing of Salvage Hormonal Therapy in Prostate Cancer Patients With Unfavorable Prognosis Treated With Radiotherapy: A Secondary Analysis of Radiation Therapy Oncology Group 85-31

✍ Luis Souhami; Kyounghwa Bae; Miljenko Pilepich; Howard Sandler 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 411 KB

Time to prostate-specific antigen nadir

Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy

✍ Toni K. Choueiri; Wanling Xie; Anthony V. D'Amico; Robert W. Ross; Jim C. Hu; Ma 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB 👁 2 views

Detection of pelvic lymph node micrometa

Detection of pelvic lymph node micrometastasis by real-time reverse transcriptase polymerase chain reaction in prostate cancer patients after hormonal therapy

✍ Liu, Ding-yi; Xia, Wei-mu; Tang, Qi; Wang, Jian; Wang, Min-wei; Wang, Ying; Wang 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 480 KB

Magnetic resonance spectroscopy in patie

Magnetic resonance spectroscopy in patients with locally confined prostate cancer: association of prostatic citrate and metabolic atrophy with time on hormone deprivation therapy, PSA level, and biopsy Gleason score

✍ Ullrich G. Mueller-Lisse; Mark G. Swanson; Daniel B. Vigneron; John Kurhanewicz 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 131 KB

Determination of growth fraction in adva

Determination of growth fraction in advanced prostate cancer by KI-67 immunostaining and its relationship to the time to tumor progression after hormonal therapy

✍ Marcus V. Sadi; Evelyn R. Barrack 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 701 KB